Genetox

Genetox is a South Korea-based private biopharmaceutical company focused on botulinum toxin type A products for cosmetic and therapeutic use. The company appears to be developing BOTAONE, a botulinum toxin program intended initially for glabellar lines while also positioning the product for broader aesthetic and medical indications. In addition to product development, Genetox presents itself as a toxin R&D and CDMO company with proprietary strain technology and integrated drug substance and drug product manufacturing capabilities. The company has also highlighted the use of non-animal potency testing through a collaboration with Curi Bio and DreamCIS to support regulatory development, including U.S. FDA-directed work. Overall, Genetox is best characterized as an emerging Korean botulinum toxin developer with manufacturing and licensing ambitions.